The higher prevalence of TTR variants identified supports the greater awareness for TTR amyloidosis in Portugal, allowing for early diagnosis, follow-up, and treatment, including liver transplant, pharmacotherapy, and an implantable cardioverter-defibrillator when indicated. This evidence concerns the gene TTR and amyloidosis.